CD4 and neoplasm: The authors went further in dissecting the underlying mechanism by showing that controlled stimulation of dendritic cell P2X7R triggered the release of IL-18 (but curiously not of IL-1β) that in turn stimulated anti-tumor activity of NK and CD4+ lymphocytes.